natgillin/translations-raw huggingface dataset:
The overall amount to be set aside by a phonogram producer for payment of the annual supplementary remuneration referred to in paragraph 2b shall correspond to 20 % of the revenue which the phonogram producer has derived, during the year preceding that for which the said remuneration is paid, from the reproduction, distribution and making available of the phonogram in question, following the 50th year after it was lawfully published or, failing such publication, the 50th year after it was lawfully communicated to the public.
Skupni znesek, ki ga mora proizvajalec fonogramov nameniti za plačilo letnega dodatnega nadomestila iz odstavka 2b, ustreza 20 % prihodkov, ki jih je proizvajalec fonogramov dobil v letu pred letom, za katero se zagotovi navedeno nadomestilo, iz reprodukcije, distribucije in dajanja v najem zadevnih fonogramov, takoj po izteku 50. leta od zakonite izdaje fonograma ali, če posnetek ni bil izdan, po izteku 50. leta od njegove zakonite priobčitve javnosti.
Member States shall ensure that phonogram producers are required on request to provide to performers who are entitled to the annual supplementary remuneration referred to in paragraph 2b any information which may be necessary in order to secure payment of that remuneration.
Države članice zagotovijo, da morajo proizvajalci fonogramov izvajalcem, ki so upravičeni do dodatnega letnega nadomestila iz odstavka 2b, na njihovo zahtevo posredovati vse informacije, ki so lahko potrebne za zavarovanje plačila tega nadomestila.
Member States shall ensure that the right to obtain an annual supplementary remuneration as referred to in paragraph 2b is administered by collecting societies.
Države članice zagotovijo, da pravico do pridobitve dodatnega letnega nadomestila iz odstavka 2b upravlja kolektivna organizacija.
Where a performer is entitled to recurring payments, neither advance payments nor any contractually defined deductions shall be deducted from the payments made to the performer following the 50th year after the phonogram was lawfully published or, failing such publication, the 50th year after it was lawfully communicated to the public.’.
Če je izvajalec upravičen do ponavljajočih se nadomestil, se mu pri plačilih ne sme odbiti niti predplačil niti kakršnih koli pogodbeno določenih odbitkov v 50. letu od zakonite izdaje fonograma ali, če ni bil izdan, v 50. letu od njegove zakonite priobčitve javnosti.“;
The following paragraphs shall be added to Article 10:
v členu 10 se dodata naslednja odstavka:
Article 3(1) to (2e) in the version thereof in force on 31 October 2011 shall apply to fixations of performances and phonograms in regard to which the performer and the phonogram producer are still protected, by virtue of those provisions in the version thereof in force on 30 October 2011, as at 1 November 2013 and to fixations of performances and phonograms which come into being after that date.
Člen 3(1) do (2e) v različici, ki je v veljavi dne 31. oktobra 2011, se uporablja za posnetke izvedb in fonograme, v zvezi s katerimi sta izvajalec in proizvajalec fonogramov 1. novembra 2013 še varovana na podlagi teh določb v različici, ki je v veljavi dne 30. oktobra 2011, in za posnetke izvedb in fonograme, ki bodo nastali po tem datumu.
Article 1(7) shall apply to musical compositions with words of which at least the musical composition or the lyrics are protected in at least one Member State on 1 November 2013, and to musical compositions with words which come into being after that date.
Člen 1(7) se uporablja za skladbe z besedilom, pri katerih sta vsaj skladba ali besedilo 1. novembra 2013 varovana v vsaj eni državi članici in za skladbe z besedilom, nastale po tem datumu.
In the absence of clear contractual indications to the contrary, a contract on transfer or assignment concluded before 1 November 2013 shall be deemed to continue to produce its effects beyond the moment at which, by virtue of Article 3(1) in the version thereof in force on 30 October 2011, the performer would no longer be protected.
Če ni jasnih pogodbenih navedb o nasprotnem, velja pogodba o prenosu ali dodelitvi, sklenjena pred 1. novembrom 2013, tudi po tem, ko izvajalec v skladu s členom 3(1) v različici, ki je v veljavi dne 30. oktobra 2011, ne bi bil več varovan.
Member States may provide that contracts on transfer or assignment which entitle a performer to recurring payments and which are concluded before 1 November 2013 can be modified following the 50th year after the phonogram was lawfully published or, failing such publication, the 50th year after it was lawfully communicated to the public.’.
Države članice lahko določijo, da se pogodbe o prenosu ali dodelitvi, po katerih je izvajalec upravičen do ponavljajočih se plačil in so sklenjene pred 1. novembrom 2013, lahko spremenijo po 50. letu od zakonite izdaje fonograma ali, če ta ni bil izdan, po 50. letu od njegove zakonite priobčitve javnosti.“.
By 1 November 2016, the Commission shall submit to the European Parliament, the Council and the European Economic and Social Committee a report on the application of this Directive in the light of the development of the digital market, accompanied, where appropriate, by a proposal for the further amendment of Directive 2006/116/EC.
Komisija do 1. novembra 2016 Evropskemu parlamentu, Svetu in Evropskemu ekonomsko-socialnemu odboru predloži poročilo o izvajanju te direktive ob upoštevanju razvoja digitalnega trga, ki ga po potrebi spremljajo predlogi za nadaljnjo spremembo Direktive 2006/116/ES.
By 1 January 2012, the Commission shall submit a report to the European Parliament, the Council and the European Economic and Social Committee, assessing the possible need for an extension of the term of protection of rights to performers and producers in the audiovisual sector.
Do 1. januarja 2012 Komisija predloži poročilo Evropskemu parlamentu, Svetu in Evropskemu ekonomsko-socialnemu odboru, v katerem oceni potrebo po podaljšanju obdobja varovanja pravic izvajalcev in proizvajalcev v avdiovizualnem sektorju.
If appropriate, the Commission shall submit a proposal for the further amendment of Directive 2006/116/EC.
Po potrebi Komisija predloži predloge za nadaljnjo spremembo Direktive 2006/116/ES.
OJ C 182, 4.8.2009, p. 36.
UL C 182, 4.8.2009, str. 36.
Position of the European Parliament of 23 April 2009 (OJ C 184 E, 8.7.2010, p. 331) and Decision of the Council of 12 September 2011.
Stališče Evropskega parlamenta z dne 23. aprila 2009 (UL C 184 E, 8.7.2010, str. 331) in odločitev Sveta z dne 12. septembra 2011.
The first subparagraph of this paragraph shall be without prejudice to any acts of exploitation performed before 1 November 2013.
Prvi pododstavek tega odstavka ne posega v nobeno dejanje uporabe, izvedeno pred 1. novembrom 2013.
Member States shall adopt the necessary provisions to protect, in particular, acquired rights of third parties.’.
Države članice sprejmejo potrebne določbe za varstvo zlasti pridobljenih pravic tretjih strank.“;
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 November 2013.
Države članice uveljavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, do 1. novembra 2013.
Commission Directive 2011/78/EU
Direktiva Komisije 2011/78/EU
amending Directive 98/8/EC of the European Parliament and of the Council to include Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev bakterije Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, kot aktivne snovi v Prilogo I k Direktivi
That list includes Bacillus thuringiensis subsp. israelensis Serotype H14.
Seznam vključuje bakterijo Bacillus thuringiensis subsp. israelensis, serotip H14.
Pursuant to Regulation (EC) No 1451/2007, Strain AM65-52 of Bacillus thuringiensis subsp. israelensis Serotype H14, has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja bakterije Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, za uporabo v 18. vrsti izdelkov (insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev), kot je opredeljena v Prilogi V k navedeni direktivi.
Strain SA3A of Bacillus thuringiensis subsp. israelensis Serotype H14 is still under evaluation for use in that product-type.
Uporaba seva SA3A bakterije Bacillus thuringiensis subsp. israelensis, serotip H14, v navedeni vrsti izdelkov se še vedno presoja.
Italy was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 11 July 2008 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Italija, ki je bila imenovana za državo članico poročevalko, je 11. julija 2008 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji predložila poročilo pristojnega organa in priporočilo.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 6 May 2011, in an assessment report.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile 6. maja 2011 ugotovitve pregleda v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
It appears from the evaluations that biocidal products used as insecticides, acaricides and products to control other arthropods and containing Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52, may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Presoje so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi, akaricidi in pripravki za nadzor drugih členonožcev ter vsebujejo bakterijo Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 in Annex I to that Directive.
Zato je bakterijo Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, primerno vključiti v Prilogo I k navedeni direktivi.
Not all potential uses have been evaluated at Union level.
Na ravni Unije ni bila opravljena presoja vseh možnih uporab.
It is therefore appropriate that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno, da države članice ocenijo možne uporabe oziroma scenarije izpostavljenosti ter tveganja za populacije ljudi in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali določijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
In the light of the potential risks identified for professional use without personal protective equipment, it is appropriate to require that product authorisations for professional use are granted only for use with appropriate personal protective equipment, unless it can be demonstrated in the application for product authorisation that risks to professional users can be reduced to an acceptable level by others means.
Zaradi ugotovljenega potencialnega tveganja za zdravje nezaščitenega poklicnega uporabnika je pri izdaji dovoljenj za pripravke primerno zahtevati, da se pripravki, namenjeni poklicni uporabi, smejo uporabljati le z ustrezno osebno zaščitno opremo, razen če se lahko v vlogi za izdajo dovoljenja za pripravek dokaže, da je tveganje za poklicne uporabnike mogoče zmanjšati na sprejemljivo raven z drugimi sredstvi.
In the light of the possible indirect human exposure via consumption of food as a result of those uses represented in the assessment, it is appropriate to require, where relevant, verification of the need to set new or to amend existing maximum residue levels according to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council [3] or Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC [4].
Glede na možno posredno izpostavljenost ljudi prek uživanja hrane zaradi uporabe, predstavljene v oceni, je po potrebi primerno zahtevati, da se preveri potreba po določitvi novih ali spremembi obstoječih najvišjih mejnih vrednosti ostankov v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta z dne 6. maja 2009 o določitvi postopkov Skupnosti za določitev mejnih vrednosti ostankov farmakološko aktivnih snovi v živilih živalskega izvora in razveljavitvi Uredbe Sveta (EGS) št. 2377/90 in spremembi Direktive 2001/82/ES Evropskega parlamenta in Sveta ter Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta [3] ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005 z dne 23. februarja 2005 o mejnih vrednostih ostankov pesticidov v ali na hrani in krmi rastlinskega in živalskega izvora ter o spremembi Direktive Sveta 91/414/EGS [4].
Measures should be adopted ensuring that the applicable maximum residue levels are not exceeded.
Sprejeti je treba ukrepe za zagotovitev, da se veljavne najvišje mejne vrednosti ostankov ne presežejo.
The provisions of this Directive should be applied at the same time in all Member States in order to ensure equal treatment on the Union market of biocidal products containing the active substance Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 and also to facilitate the proper operation of the market for biocidal products in general.
Določbe te direktive se morajo uporabljati hkrati v vseh državah članicah, da bi bilo tako zagotovljeno enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, na trgu Unije in omogočeno ustrezno delovanje trga biocidnih pripravkov na splošno.
A reasonable period should be allowed to elapse before an active substance is included in Annex I to Directive 98/8/EC, in order to permit Member States and interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.
Pred vključitvijo aktivne snovi v Prilogo I k Direktivi 98/8/ES je treba zagotoviti ustrezno obdobje, ki bo državam članicam in zainteresiranim stranem omogočilo, da se pripravijo na izpolnjevanje novih zahtev, prijaviteljem, ki so pripravili dokumentacijo, pa, da lahko povsem izkoristijo desetletno obdobje za varstvo podatkov, ki se v skladu s členom 12(1)(c)(ii) Direktive 98/8/ES začne z dnem vključitve.
Member States shall adopt and publish, by 30 September 2012 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje 30. septembra 2012 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 1 October 2013.
Navedene predpise uporabljajo od 1. oktobra 2013.
Product-type
Vrsta izdelkov
Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52
Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52
No relevant impurities
Relevantnih nečistoč ni.
1 October 2013
1. oktober 2013
When assessing the application for authorisation of a product in accordance with Article 5 and Annex VI, Member States shall assess, where relevant for the particular product, those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment.
Kadar je za določen pripravek to potrebno, države članice pri ocenjevanju vloge za izdajo dovoljenja za pripravek v skladu s členom 5 in Prilogo VI ocenijo možne uporabe oziroma scenarije izpostavljenosti ter tveganja za populacije ljudi in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije.
Products authorised for professional use shall be used with appropriate personal protective equipment, unless it can be demonstrated in the application for product authorisation that risks to professional users can be reduced to an acceptable level by other means.
Pripravki, za katere je izdano dovoljenje za poklicno uporabo, se uporabljajo z ustrezno osebno zaščitno opremo, razen če se lahko v vlogi za izdajo dovoljenja za pripravek dokaže, da je tveganje za poklicne uporabnike mogoče zmanjšati na sprejemljivo raven z drugimi sredstvi.
For products containing Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 that may lead to residues in food or feed, Member States shall verify the need to set new or to amend existing maximum residue levels (MRLs) according to Regulation (EC) No 470/2009 or Regulation (EC) No 396/2005, and take any appropriate risk mitigation measures ensuring that the applicable MRLs are not exceeded.’
Za pripravke, ki vsebujejo bakterijo Bacillus thuringiensis subsp. israelensis, serotip H14, sev AM65-52, in lahko puščajo ostanke v živilih ali krmi, države članice preverijo potrebo po določitvi novih ali spremembi obstoječih najvišjih mejnih vrednosti ostankov v skladu z Uredbo (ES) št. 470/2009 ali Uredbo (ES) št. 396/2005 in sprejmejo vse primerne ukrepe za zmanjšanje tveganja, s čimer se zagotovi, da veljavne najvišje mejne vrednosti niso presežene.“
For the implementation of the common principles of Annex VI, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/comm/environment/biocides/index.htm
Za izvajanje splošnih načel Priloge VI so vsebina in sklepne ugotovitve poročil o oceni na voljo na naslednji spletni strani Komisije: http://ec.europa.eu/comm/environment/biocides/index.htm.
Commission Directive 2011/79/EU
Direktiva Komisije 2011/79/EU
amending Directive 98/8/EC of the European Parliament and of the Council to include fipronil as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev fipronila kot aktivne snovi v Prilogo I k Direktivi
That list includes fipronil for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to the Directive.
Navedeni seznam vključuje fipronil za uporabo v 18. vrsti izdelkov, insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev, kot je opredeljena v Prilogi V k navedeni direktivi.
Pursuant to Regulation (EC) No 1451/2007, fipronil has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja fipronila glede uporabe v 18. vrsti izdelkov.
France was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007 on 6 February 2009.
Francija, ki je bila imenovana za državo članico poročevalko, je 6. februarja 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji predložila poročilo pristojnega organa in priporočilo.
It appears from the evaluations that biocidal products used as insecticides and containing fipronil may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Presoje so pokazale, da je za biocidne pripravke, ki se uporabljajo kot insekticidi in vsebujejo fipronil, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include fipronil in Annex I to that Directive.
Zato je primerno vključiti fipronil v Prilogo I k navedeni direktivi.
Not all potential uses have been evaluated in the Union level assessment, which only addressed professional use indoors by application in locations normally inaccessible to man and domestic animals after application.
V oceni na ravni Unije ni bila opravljena presoja za vse možnosti uporabe, ampak samo za poklicne uporabe v zaprtih prostorih na mestih, ki po uporabi navadno niso dostopni ljudem in domačim živalim.
It is therefore appropriate to require that Member States assess those uses or exposure scenarios and those risks to human populations and to environmental compartments that have not been representatively addressed in the Union level risk assessment and, when granting product authorisations, ensure that appropriate measures are taken or specific conditions imposed in order to reduce the identified risks to acceptable levels.
Zato je primerno od držav članic zahtevati, da ocenijo možne uporabe oziroma scenarije izpostavljenosti ter tista tveganja za populacije ljudi in dele okolja, ki niso bili reprezentativno obravnavani v oceni tveganja na ravni Unije, ter da pri izdaji dovoljenj za pripravke zagotovijo, da se sprejmejo ustrezni ukrepi ali določijo posebni pogoji za zmanjšanje ugotovljenih tveganj na sprejemljivo raven.
The provisions of this Directive should be applied at the same time in all Member States in order to ensure equal treatment on the Union market of biocidal products containing the active substance fipronil, and also to facilitate the proper operation of the biocidal products market in general.
Določbe te direktive se morajo uporabljati hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki, ki vsebujejo aktivno snov fipronil, na trgu Unije in tudi da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
A reasonable period should be allowed to elapse before an active substance is included in Annex I to Directive 98/8/EC in order to permit Member States and interested parties to prepare themselves to meet the new requirements entailed and to ensure that applicants who have prepared dossiers can benefit fully from the 10-year period of data protection, which, in accordance with Article 12(1)(c)(ii) of Directive 98/8/EC, starts from the date of inclusion.
Pred vključitvijo aktivne snovi v Prilogo I k Direktivi 98/8/ES je treba zagotoviti ustrezno dolgo obdobje, ki bo državam članicam in zainteresiranim stranem omogočilo, da se pripravijo na izpolnjevanje novih zahtev, prijaviteljem, ki so pripravili dokumentacijo, pa, da lahko povsem izkoristijo desetletno obdobje za varstvo podatkov, ki se v skladu s členom 12(1)(c)(ii) Direktive 98/8/ES začne z dnem vključitve.
The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on Biocidal Products,
Ukrepi iz te direktive so v skladu z mnenjem Stalnega odbora za biocidne pripravke –
Product-type
Vrsta izdelka
(±)-5-amino-1-(2,6-dichloro-α,α,α,-trifluoro-p-tolyl)-4-trifluoromethylsulfinylpyrazole-3-carbonitrile (1:1)
(±)-5-amino-1-(2,6-dikloro-α,α,α-trifluoro-p-tolil)-4-trifluorometilsulfinilpirazol-3-karbonitril (1:1)
EC No: 424-610-5
Št. ES: 424-610-5
Only professional use indoors by application in locations normally inaccessible after application to man and domestic animals has been addressed in the Union level risk assessment.
V oceni tveganja na ravni Unije so bile obravnavane samo poklicne uporabe v zaprtih prostorih na mestih, ki po uporabi navadno niso dostopni ljudem in domačim živalim.